WAVEMAN · COMPANY

MMSI · Merit Medical Systems Inc

LIVE

TEAM-2.62% 13F +440META+1.00% 13F +2,694RCG+0.35% CLUSTERUTHR-0.54% 13F +425CRWV+5.68% 13F +694CRM-1.97% 13F +1,019CVNA+1.58% 13F +795TPL-1.11% 13F +444NET-1.96% 13F +711MSTR-1.39% 13F +527DELL+1.50% 13F +1,204CRWD-0.87% 13F +1,383ANET+1.22% 13F +1,324COIN-4.18% 13F +475TEAM-2.62% 13F +440META+1.00% 13F +2,694RCG+0.35% CLUSTERUTHR-0.54% 13F +425CRWV+5.68% 13F +694CRM-1.97% 13F +1,019CVNA+1.58% 13F +795TPL-1.11% 13F +444NET-1.96% 13F +711MSTR-1.39% 13F +527DELL+1.50% 13F +1,204CRWD-0.87% 13F +1,383ANET+1.22% 13F +1,324COIN-4.18% 13F +475

← ALL COMPANIES

MMSI

Name: MERIT MEDICAL SYSTEMS INC (MMSI) insider trading and ownership data
Creator: WaveMan
License: https://wave-man.com/terms

MERIT MEDICAL SYSTEMS INC

MEDICAL DEVICES · SURGICAL & MEDICAL INSTRUMENTS & APPARATUS · CIK 0000856982

CLUSTER · 5 INSIDERSC-SUITE BUYING · 5FORM 144 · 2☆ WATCH

INSIDER NET · 180D

-$2.2M

open-market buys minus sells, Form 4 codes P and S

INSIDER BUYERS · 180D

CONGRESS BUYERS · 1Y

FUNDS ADDED · QTR

13F, latest reported quarter

REVENUE GROWTH

+11.8%

XBRL, annual

NET MARGIN

8.5%

CONVERSIONS · 180D

codes C/M, not in net · $1.1M priced

SEVEN FACTS, RANKED AGAINST THE SECTOR · RANK IS NOT A FORECAST

INSIDERS

net -$2.2M over 180 days

-$2.5M over 90 days

below 66% of Medical Devices

CONGRESS

no member of Congress has reported trading it

FUNDS

fewer than five institutions report holding it

REVENUE

+11.8% year over year

more than 59% of Medical Devices

MARGIN

8.5% net margin

more than 74% of Medical Devices

BUYBACKS

no share repurchases reported

SHORT

6.3% of shares outstanding short · 3.7 days to cover · settled 2026-07-31

more than 73% of Medical Devices

The year, with the filings on it

Total return indexed to 100 over the last 12 months · every marker is a federal filing, placed at its date — hover any marker for the detail

TOTAL 12M RETURN -1.2%

-1.2%12M

INSIDER BUYINSIDER SELLFORM 144

INDEXED RETURN, DIVIDEND-ADJUSTED — NOT A PRICE CHART · LARGE TRADES DRAWN FIRST WHEN A NAME FILES HEAVILY

Live price

Daily candles from TradingView, on their licence — no filings are marked on this one

WHY THIS NAME IS ON THE DESK

5 insiders reported buying shares.

The record shows a net $2.2M sold by insiders over 180 days, $2.5M in planned Form 144 sales. Every figure is a federal filing, dated the day it became public.

Backtest this pattern Open the screener

Same sector, ranked by filing activity

Sector from the SEC's own SIC classification

TMO PEN ROK BLFS MTD SIBN WRBY ISRG TXG DXCM EW TMDX

Insider transactions

Form 4 purchases and sales (codes P and S) — grants, option exercises and preferred conversions excluded

Over the last 180 days, MERIT MEDICAL SYSTEMS INC insiders sold a net $2.2M of stock across 76 Form 4 purchases and sales, with 5 insider(s) buying. Source: SEC Form 4 filings, as of 2026-09-06.

INSIDER

FILED

VALUE

Peterson Neil W.

CHIEF OPERATING OFFICER

SELL

2026-08-24

7,500.0

$678.4K

Peterson Neil W.

CHIEF OPERATING OFFICER

SELL

2026-08-04

21,449.0

$1.8M

Smith Christian Adam

Chief Commercial Officer

BUY

2026-05-11

1,626.0

$99.2K

Ward Lynne N.

Director

SELL

2026-05-07

5,000.0

$313.1K

Lloyd Brian G.

CHIEF LEGAL OFFICER, SECRETARY

BUY

2026-05-07

2,000.0

$125.3K

76 TRANSACTIONS ON RECORD

Showing the most recent few. Create a free account to see 71 more transactions on record, the cross-source screener and CSV export. We store only your email address, and there is no password to create.

Institutional holders

13F · holdings as of the latest quarter funds have reported

no 13F holders found for this ticker

SCHEDULE 13D/G

No 5%+ ownership filings

Nobody has crossed 5% with a filing obligation. Absence is a fact here, not missing data.

Planned sales · Form 144

Filed before the sale — intent, not a trade

NEIL W PETERSON

FILED 2026-08-24

$678.4K

NEIL W PETERSON

FILED 2026-08-04

$1.8M

Clinical pipeline

ClinicalTrials.gov · 16 registered trials, 8 still enrolling or running — a status change here is dated weeks before the press release

Not applicable

8 ACTIVE

TRIALS MATCHED TO THIS TICKER BY SPONSOR NAME · STUDIES RUN UNDER A SUBSIDIARY'S OWN NAME ARE NOT INCLUDED

Corporate PAC

FEC · the company-connected political action committee's own receipts and spending — committee totals only, never individual donors

Merit Medical Systems Inc Employee Good Governance Pac

CYCLE 2026 · $11K SPENT

$34.2K

FEDERAL ELECTION COMMISSION · MATCHED BY THE PAC'S CONNECTED ORGANISATION

Executive pay vs shareholder return

DEF 14A pay-versus-performance disclosure · both the headline pay and the SEC's mark-to-market figure, beside the return the company delivered and the return of the peer group it chose itself

CEO TOTAL

ACTUALLY PAID

OTHER NEOs AVG

TSR

PEER TSR

2020

$7.7M

$12.6M

$1.7M

+78%

+47%

TAGGED BY THE COMPANY UNDER SEC ITEM 402(v) · RETURN IS CUMULATIVE FROM THE START OF THE DISCLOSURE PERIOD · GREEN WHERE THE COMPANY BEAT ITS OWN PEER GROUP

Fundamentals

Annual figures from XBRL filings · pick a past date to see them exactly as the market knew them then — restatements and all

	2025-12	2024-12	2023-12	2022-12
REVENUE	$1.5B	$1.4B	$1.3B	$1.2B
GROSS PROFIT	$738.3M	$643.3M	$583.9M	$519.1M
OPERATING INCOME	$184.7M	$155.7M	$123.9M	$87.6M
NET INCOME	$128.5M	$120.4M	$94.4M	$74.5M
EPS (DILUTED)	2.13	2.03	1.62	1.29
OPERATING CASH FLOW	$297.4M	$220.8M	$145.2M	$114.3M
CASH	$446.4M	$376.7M	$587.0M	$58.4M
LONG-TERM DEBT	$734.0M	$729.6M	$823.0M	$186.8M

SEC XBRL · FISCAL-YEAR PERIODS · AS KNOWN ON 2026-09-06 · NOBODY ELSE SHOWS FUNDAMENTALS AS OF A PAST DATE